تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر تاناتريل 10مجم 14 اقراص 2022

Tanatril 10mg 14 tab

معلومات الدواء

التفاصيل الكاملة
عن الدواءAbout the medicine

Imidapril 10 mg tablets, pack of 14, marketed in Egypt by Hikma Pharma (ACE inhibitor antihypertensive).

Imidapril 10 mg tablets, pack of 14, marketed in Egypt by Hikma Pharma (ACE inhibitor antihypertensive).

دواعي الاستعمالUses
  • Treatment of essential hypertension in adults.الفئة: AdultsNorthumbria Pharma Ltd (UK MAH)
  • Treatment of essential hypertension in adults.Population: AdultsNorthumbria Pharma Ltd (UK MAH)
الآثار الجانبيةSide effects
  • Common: cough. Uncommon: headache, dizziness, hypotension, rash, pruritus. Rare: insomnia, dysgeusia, tinnitus, palpitations, nausea, vomiting, diarrhoea, abdominal pain, renal impairment, proteinuria, oedema, fatigue.نشرة دولية لتركيبة مكافئة · Northumbria Pharma Ltd (UK MAH)
  • Common: cough. Uncommon: headache, dizziness, hypotension, rash, pruritus. Rare: insomnia, dysgeusia, tinnitus, palpitations, nausea, vomiting, diarrhoea, abdominal pain, renal impairment, proteinuria, oedema, fatigue.International label, equivalent formulation · Northumbria Pharma Ltd (UK MAH)
موانع الاستعمالContraindications
  • Hypersensitivity to imidapril, any other ACE inhibitor or excipients; history of ACE-inhibitor angioedema; hereditary/idiopathic angioedema; second and third trimesters of pregnancy; renal failure (CrCl < 10 ml/min); aliskiren in patients with diabetes or GFR < 60 ml/min/1.73 m2; concomitant sacubitril/valsartan.نشرة دولية لتركيبة مكافئة · Northumbria Pharma Ltd (UK MAH)
  • Hypersensitivity to imidapril, any other ACE inhibitor or excipients; history of ACE-inhibitor angioedema; hereditary/idiopathic angioedema; second and third trimesters of pregnancy; renal failure (CrCl < 10 ml/min); aliskiren in patients with diabetes or GFR < 60 ml/min/1.73 m2; concomitant sacubitril/valsartan.International label, equivalent formulation · Northumbria Pharma Ltd (UK MAH)
تحذيرات واحتياطاتWarnings & precautions
  • May cause profound hypotension, especially after the first dose in volume-depleted patients or severe heart failure; start with 2.5 mg under close supervision in high-risk patients.نشرة دولية لتركيبة مكافئة · Northumbria Pharma Ltd (UK MAH)
  • Neutropenia/agranulocytosis, thrombocytopenia and anaemia reported rarely with ACE inhibitors; extreme caution in collagen vascular disease, immunosuppression, allopurinol or procainamide treatment, especially with renal impairment.نشرة دولية لتركيبة مكافئة · Northumbria Pharma Ltd (UK MAH)
  • Hyperkalaemia may occur, especially with renal insufficiency, diabetes, potassium-sparing diuretics, potassium supplements or salt substitutes.نشرة دولية لتركيبة مكافئة · Northumbria Pharma Ltd (UK MAH)
  • May cause profound hypotension, especially after the first dose in volume-depleted patients or severe heart failure; start with 2.5 mg under close supervision in high-risk patients.International label, equivalent formulation · Northumbria Pharma Ltd (UK MAH)
  • Neutropenia/agranulocytosis, thrombocytopenia and anaemia reported rarely with ACE inhibitors; extreme caution in collagen vascular disease, immunosuppression, allopurinol or procainamide treatment, especially with renal impairment.International label, equivalent formulation · Northumbria Pharma Ltd (UK MAH)
  • Hyperkalaemia may occur, especially with renal insufficiency, diabetes, potassium-sparing diuretics, potassium supplements or salt substitutes.International label, equivalent formulation · Northumbria Pharma Ltd (UK MAH)
التداخلات الدوائيةDrug interactions
  • Potassium-sparing diuretics / potassium supplements / potassium-containing salt substitutesMay cause significant, potentially lethal increases in serum potassium, especially with renal impairment; avoid unless hypokalaemia, and monitor potassium.Northumbria Pharma Ltd (UK MAH)
  • Non-potassium-sparing diureticsRisk of sudden hypotension and/or acute renal impairment when starting the ACE inhibitor in salt/volume-depleted patients.Northumbria Pharma Ltd (UK MAH)
  • Potassium-sparing diuretics / potassium supplements / potassium-containing salt substitutesMay cause significant, potentially lethal increases in serum potassium, especially with renal impairment; avoid unless hypokalaemia, and monitor potassium.Northumbria Pharma Ltd (UK MAH)
  • Non-potassium-sparing diureticsRisk of sudden hypotension and/or acute renal impairment when starting the ACE inhibitor in salt/volume-depleted patients.Northumbria Pharma Ltd (UK MAH)
الحمل والرضاعةPregnancy & breastfeeding
  • When pregnancy is diagnosed, stop the ACE inhibitor immediately and start alternative therapy if appropriate.نشرة دولية لتركيبة مكافئة · Northumbria Pharma Ltd (UK MAH)
  • When pregnancy is diagnosed, stop the ACE inhibitor immediately and start alternative therapy if appropriate.International label, equivalent formulation · Northumbria Pharma Ltd (UK MAH)
كيف يعمل الدواءHow it works
  • Prodrug converted to imidaprilat, which inhibits angiotensin-converting enzyme and reduces angiotensin II formation.
  • Imidapril: Prodrug converted to imidaprilat, which inhibits angiotensin-converting enzyme and reduces angiotensin II formation.

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.